0001974158-24-000021.txt : 20240410
0001974158-24-000021.hdr.sgml : 20240410
20240410161159
ACCESSION NUMBER: 0001974158-24-000021
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240410
DATE AS OF CHANGE: 20240410
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Enliven Therapeutics, Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811523849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 24835903
BUSINESS ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-647-8519
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: IMARA Inc.
DATE OF NAME CHANGE: 20160419
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ballal Rahul D.
CENTRAL INDEX KEY: 0001805097
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 116 HUNTINGTON AVENUE
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
144
1
primary_doc.xml
144
0001805097
XXXXXXXX
LIVE
0001672619
Enliven Therapeutics, Inc.
001-39247
6200 LOOKOUT ROAD
BOULDER
CO
80301
720-647-8519
Ballal Rahul D.
Director
Common
Jefferies LLC
520 Madison Ave
4th Fl
New York
NY
10022
20000
383000.00
41200000
04/10/2024
NASDAQ
Common
10/19/2018
Options Grant
Enliven Therapeutics, inc.
N
20000
10/19/2018
10/19/2018
N
Rahul D Ballal
6200 Lookout Road, First Floor
Boulder
CO
80301
Enliven Therapeutics, Inc.
03/20/2024
13278
254462.00
Rahul D Ballal
6200 Lookout Road, First Floor
Boulder
CO
80301
Enliven Therapeutics, Inc.
04/01/2024
3237
61758.33
Rahul D Ballal
6200 Lookout Road, First Floor
Boulder
CO
80301
Enliven Therapeutics, Inc.
04/04/2024
3485
66729.25
All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 10/19/2023, and all representations regarding material non-public information were made as of the adoption of the plan.
04/10/2024
10/19/2023
Rahul Ballal